The Specific Aim of this application is for the University of Utah Clinical Center to achieve successful entry into the NICHD Neonatal Research Network (NRN) for the 2016-2021 cycle. The Utah Center was previously an active NRN participant during the 2006-2011 with strong participation in patient recruitment, NRN committee activities, and involvement in design and submission of several past or on-going NRN study protocols. Though currently not an active NRN Center, the Utah Center has continued to actively provide neonatal follow-up for several on-going studies, including 6-7 year follow-up for SUPPORT. The Utah Center has continued active participation in several large, non-NRN, multi-center randomized trials. The Principal Investigator, Dr. Bradley A. Yoder, has past and on-going participation in development, design manuscript writing, and oversight as PI and/or steering committee member for many of these non-NRN trials. The current proposal includes an expanded number of Utah Neonatal Intensive Care Unit (NICU) sites; in line with centers that have been active members of the Utah Maternal-Fetal Medicine Unit (MFMU) Network for the past 20 years. The Utah Center now includes 5 sites with 250 NICU beds and over 4,000 NICU admissions per year; representing nearly 90% of all Utah NICU care and almost 100% of all ELGAN/ELBW infants. Specific strengths of the Utah Center include 1) a population base unique from most other NRN Centers including a relatively high socioeconomic profile and a high proportion of non-Hispanic Caucasians; 2) established expertise in design, management, and analysis of multi-center randomized trials; 3) productive collaborative contributions to over 15 large randomized trials over the past decade; 4) past and current collaborative research studies within the University of Utah and Intermountain Healthcare consortium; 5) experienced research staff and support infrastructure including University of Utah Center for Clinical and Translational Science, Pediatric Pharmacology Program, and Institute of Women's and Child research; 6) productive research collaboration with Utah MFMU sites and faculty; 7) an enhanced Neonatal Follow-Up Program now integrated into the Department of Pediatrics; and 8) documented support from senior leadership across both the University of Utah Health Sciences and Intermountain Healthcare, including Medical Directors of the NICUs and MFMU sites at all participating hospitals. With the leadership of Dr. Yoder, the University of Utah has established productivity as a clinical trial site. An established research infrastructure, strong Neonatal Follow-Up program, and collaborative activities across a wide spread community, coupled with the highly successful Utah MFMU are major factors positioning the Utah Center for selection as a NRN study site.

Public Health Relevance

Survival of all neonates has dramatically improved, particularly those at less than 1,000 grams. Proven, cost- effective approaches to further reduce significant morbidities are essential to survivors' long-term health and to society. Large multi-center trials with varied ethnic-racial-socioeconomic background are necessary for outcome validation and generalizability. The Utah Center is ready to be a leading member of the NICHD Neonatal Research Network, the world's premier neonatal clinical trials group.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Clinical Research Cooperative Agreements - Single Project (UG1)
Project #
1UG1HD087226-01
Application #
9076645
Study Section
Special Emphasis Panel (ZHD1)
Program Officer
Raju, Tonse N
Project Start
2016-04-01
Project End
2021-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Utah
Department
Pediatrics
Type
Schools of Medicine
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Di Fiore, Juliann M; Martin, Richard J; Li, Hong et al. (2017) Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. J Pediatr 186:49-56.e1
Jensen, Erik A; Dysart, Kevin C; Gantz, Marie G et al. (2017) Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. J Pediatr 186:34-40.e2
Chawla, Sanjay; Natarajan, Girija; Shankaran, Seetha et al. (2017) Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation. J Pediatr 189:113-119.e2
Lakshminrusimha, Satyan; Keszler, Martin; Kirpalani, Haresh et al. (2017) Milrinone in congenital diaphragmatic hernia - a randomized pilot trial: study protocol, review of literature and survey of current practices. Matern Health Neonatol Perinatol 3:27
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Chawla, Sanjay; Natarajan, Girija; Shankaran, Seetha et al. (2016) Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids. JAMA Pediatr 170:1164-1172
Wortham, Jonathan M; Hansen, Nellie I; Schrag, Stephanie J et al. (2016) Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections. Pediatrics 137:
Batton, Beau; Li, Lei; Newman, Nancy S et al. (2016) Early blood pressure, antihypotensive therapy and outcomes at 18-22?months' corrected age in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed 101:F201-6
Meyers, J M; Bann, C M; Stoll, B J et al. (2016) Neurodevelopmental outcomes in postnatal growth-restricted preterm infants with postnatal head-sparing. J Perinatol 36:1116-1121
Boghossian, Nansi S; McDonald, Scott A; Bell, Edward F et al. (2016) Association of Antenatal Corticosteroids With Mortality, Morbidity, and Neurodevelopmental Outcomes in Extremely Preterm Multiple Gestation Infants. JAMA Pediatr 170:593-601

Showing the most recent 10 out of 12 publications